Next Article in Journal
Nanostructured TiO2 Carbon Paste Based Sensor for Determination of Methyldopa
Next Article in Special Issue
Oxidative Stress and Cardiovascular Complications in Chronic Kidney Disease, the Impact of Anaemia
Previous Article in Journal / Special Issue
Sucrosomial® Iron: A New Generation Iron for Improving Oral Supplementation
Open AccessReview

Gut Microbiota and Iron: The Crucial Actors in Health and Disease

by 1,2,* and 1,2
1
Maurice Müller Laboratories, Department of Biomedical Research, University of Bern, 3008 Bern, Switzerland
2
University Clinic of Visceral Surgery and Medicine, Inselspital, 3010 Bern, Switzerland
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2018, 11(4), 98; https://doi.org/10.3390/ph11040098
Received: 12 September 2018 / Revised: 30 September 2018 / Accepted: 2 October 2018 / Published: 5 October 2018
(This article belongs to the Special Issue Iron as Therapeutic Targets in Human Diseases)
Iron (Fe) is a highly ample metal on planet earth (~35% of the Earth’s mass) and is particularly essential for most life forms, including from bacteria to mammals. Nonetheless, iron deficiency is highly prevalent in developing countries, and oral administration of this metal is so far the most effective treatment for human beings. Notably, the excessive amount of unabsorbed iron leave unappreciated side effects at the highly interactive host–microbe interface of the human gastrointestinal tract. Recent advances in elucidating the molecular basis of interactions between iron and gut microbiota shed new light(s) on the health and pathogenesis of intestinal inflammatory diseases. We here aim to present the dynamic modulation of intestinal microbiota by iron availability, and conversely, the influence on dietary iron absorption in the gut. The central part of this review is intended to summarize our current understanding about the effects of luminal iron on host–microbe interactions in the context of human health and disease. View Full-Text
Keywords: iron; gut microbiota; iron supplementation; iron transporters; mucosal immunity; SCFA; intestinal inflammation; inflammatory bowel disease (IBD); colorectal cancer iron; gut microbiota; iron supplementation; iron transporters; mucosal immunity; SCFA; intestinal inflammation; inflammatory bowel disease (IBD); colorectal cancer
Show Figures

Figure 1

MDPI and ACS Style

Yilmaz, B.; Li, H. Gut Microbiota and Iron: The Crucial Actors in Health and Disease. Pharmaceuticals 2018, 11, 98.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map

1
Back to TopTop